AKT1 and T-cell acute lymphoblastic leukemia: In T-cell ALL, interleukin-7 activates the phosphoinositide 3-kinase/Akt/mammalian target of rapamycin pathway and mediates ROS-dependent T cell proliferation and growth [36].